OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

Charity registration number 1205120 (England and Wales)

RAREMINDS CIO

ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

RAREMINDS CIO

LEGAL AND ADMINISTRATIVE INFORMATION

Trustees Paul Stevens
Rachel Milroy
Michael Hartnett
Dr Sarah Wynn PhD
Senior management Lauren Roberts Chief Executive Officer
Kym Winter Chief Clinical Officer
Catherine Sleath Head of Operations
Charity registration England and Wales 1205120
Registered address 86 - 90 Paul Street
London
EC2A 4NE
Independent examiner Gary Howard FCA
Howard Wilson Chartered Accountants
36 Crown Rise
Watford
Hertfordshire
WD25 0NE
Bankers The Co-operative Bank plc
1 Balloon Street
Manchester
M60 4EP

RAREMINDS CIO

CONTENTS

Page
Trustees' report 1 - 4
Statement of trustees' responsibilities 5
Independent examiner's report 6
Statement of financial activities 7 - 8
Balance sheet 9
Notes to the financial statements 10 - 18

RAREMINDS CIO

TRUSTEES' REPORT

FOR THE YEAR ENDED 31 DECEMBER 2025

The trustees present their annual report and financial statements for the year ended 31 December 2025.

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Charities Act 2011, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)".

Objectives and activities

The charitable objects of the CIO are:

To promote and protect the mental health of those suffering from the impact of rare diseases for the public benefit throughout the world by:

Our vision

Our vision is that the psychological and emotional impact of living with a rare condition is recognised as an essential part of rare condition care, ensuring everyone has access to high-quality, specialist mental health support.

Our mission

Our mission is to provide affordable, timely and expert counselling for the rare disease community. We also work to raise awareness, inform policy and promote excellence in the recognition and delivery of specialist mental health care.

Our aims

Public benefit

The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the charity should undertake and confirms compliance with the guidance on public benefit.

Activities

We have worked in partnership with 29 rare condition organisations to provide counselling and well-being services to individuals, couples, families and professionals impacted by rare conditions.

Our main activities were:

1:1 counselling sessions for individuals and couples

Our team of specialist counsellors provided 3,089 counselling sessions for 442 clients.

Therapeutic Group Programmes

We facilitated sixteen 8 week Group Programmes for 7 different rare condition organisations with a total of 165 participants. Our Group Programmes aim to ease isolation and build peer support networks.

Workshops and presentations

We delivered 13 workshops and presentations on topics like ‘Living with your rare condition’ and ‘Dealing with Diagnosis’ to 13 different rare condition organisations with a total of nearly 200 attendees.

RAREMINDS CIO

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

Patient Organisation Days and Conferences

We attended patient organisation days and conferences, delivered talks and participated in Panels at international events to raise awareness of the psychological impact of living with a rare condition. This included running a workshop on mental health at the Eurordis (Rare Diseases Europe) Membership meeting in Latvia, and a panel discussion on rare conditions and mental health at World Orphan Drug Congress in Amsterdam.

Training for Healthcare Professionals

We provided 5 training sessions for Health Care Professionals helping to enable them to support the mental health of their rare condition patients.

Psychoeducational Resources

We produced video and written resources for 6 different patient organisations and continued to develop our own online Wellbeing Hub.

Achievements and performance

Significant activities and achievements against objectives

Details of activities and significant charitable achievements against objectives during the year:

43% (123/347) of Rareminds clients start counselling with a psychological distress level of severe or moderately severe (measured using the clinical evaluation tool CORE-10).

57% (119) Rareminds clients have a psychological distress rating of health or low when they complete a series of counselling. (Based on clients who completed a start and end CORE-10).

We received feedback from 161 counselling service clients. They told us:

Feedback from clients included:

[Counsellor] really is a credit to your service. Just in the way [they] approached every session really made me feel at ease. I do find trusting people hard but it came very easy. [They] gave me great understanding of how my mind worked and why it thinks in a certain way which has helped me become more self aware.

First ever experience with counselling and I am very grateful I had the opportunity to speak to [counsellor], [they have] helped me to feel in a better place with my child’s rare genetic condition, managing my emotions around other family circumstances and childhood experiences, it’s made me more aware of why I am the person I am today and making me think of ways to recognise and managing things in the future, I will return if needed in the future as it’s been very helpful.

[Counsellor] was extremely kind, understanding, helpful and patient; [they] pushed me just enough, and helped me move forwards in my life. [They] gave me good recommendations and ideas of human behaviour patterns, and led me to find my own way into letting go of held in hard emotions, so I no longer feel like a victim in my life.

RAREMINDS CIO

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

93% of people who participated in our Autumn 2025 group programme felt that the group facilitator had a good or very good understanding of their rare condition.

91% of group participants would recommend the programme to others.

I feel this course helped me move forward with beginning to accept my diagnosis and manage the uncertainty.

I really got so much out of the sessions and would like to emphasise how much I appreciate that I was able to take part, thank you! [Counsellor] is a wonderful facilitator, very calm, helpful and gentle. She made the sessions feel like a secure space where everyone could open up, be themselves and share their experiences without judgement, whilst gently guiding us through the sessions and sharing useful tools and resources.

Financial review

During the year income was £396,527 (2024: £306,653) an increase of £89,874 on the previous period which was a 15 month period.

Expenditure was £315,686 compared to £276,377 in the 15 month period, an increase of £39,309.

The charity made a surplus for the year of £80,841 of which there was a surplus of £90,792 on unrestricted funds and a deficit of £9,951 on restricted funds. In the 15 month period there was a surplus of £30,276 of which there was a surplus of £9,657 on unrestricted funds and a surplus of £20,619 on restricted funds.

At the year end the charity had reserves to carry forward of £123,277 on unrestricted funds and £10,668 on restricted funds.

In the process of preparing the accounts for the year ended 31 December 2025 we became aware of a computational error in the accounts for the previous fifteen month period ended 31 December 2024. The error related to the balance of reserves brought forward at the start of the fifteen month period and resulted in incorrect figures being shown for reserves carried forward at 31 December 2024. The computational errors in the accounts did not affect the net movement in funds for that period. The errors have been corrected in the comparative figures shown in these accounts. The Board considered producing amended accounts for the fifteen month period to submit to the Charity Commission but ultimately decided that, because the errors affected a limited part of the information in those accounts, the time and costs involved in doing this would not be justified.

Reserves policy

It is the policy of the charity that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to three month’s operational expenditure. The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charity’s current activities while consideration is given to ways in which additional funds may be raised. This level of reserves has been increased during the year and is now in line with the policy.

Major risks

The trustees have considered the major risks to which the charity is exposed and have established procedures including a risk register to identify and manage those risks.

RAREMINDS CIO

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

Plans for future periods

The charity's plans for future periods include:

Structure, governance and management

The charity was founded as a Community Interest Company in 2021 and converted to a Charitable Incorporated Organisation (CIO) in 2023. The CIO was registered as a charity with the Charity Commission for England and Wales on 09 October 2023.

The trustees who served during the year and up to the date of signature of the financial statements were: Paul Stevens

Rachel Milroy Michael Hartnett Dr Sarah Wynn PhD

Recruitment and appointment of trustees

The current trustees were co-opted as the first trustees of the charity. Apart from the first charity trustees, every trustee must be appointed for a term of three years by a resolution passed at a properly convened meeting of the charity trustees. In selecting individuals for appointment as charity trustees, the charity trustees must have regard to the skills, knowledge and experience needed for the effective oversight and administration of the CIO.

None of the trustees has any beneficial interest in the company.

All of the trustees are members of the charity and guarantee to contribute a maximum of £100 in the event of a winding up.

The trustees' report was approved by the Board of Trustees.

Paul Stevens

Paul Stevens Trustee & Chair

29 July 2026

RAREMINDS CIO

STATEMENT OF TRUSTEES' RESPONSIBILITIES

FOR THE YEAR ENDED 31 DECEMBER 2025

The trustees are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

The law applicable to charities in England and Wales requires the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources of the charity for that year.

In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping sufficient accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the trust deed. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

RAREMINDS CIO

INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF RAREMINDS CIO

I report to the trustees on my examination of the financial statements of Rareminds CIO (the charity) for the year ended 31 December 2025.

Responsibilities and basis of report

As the trustees of the charity you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011.

I report in respect of my examination of the charity’s financial statements carried out under section 145 of the Charities Act 2011. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011.

Independent examiner's statement

Since the charity’s gross income exceeded £250,000, the independent examiner must be a member of a body listed in section 145 of the Charities Act 2011. I confirm that I am qualified to undertake the examination because I am a member of the Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.

Your attention is drawn to the fact that the charity has prepared the financial statements in accordance with the relevant version of the Statement of Recommended Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has now been withdrawn. I understand that this has been done in order for the financial statements to provide a true and fair view in accordance with UK Generally Accepted Accounting Practice.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.

Gary Howard FCA

Howard Wilson Chartered Accountants 36 Crown Rise Watford Hertfordshire WD25 0NE 10 August 2026

RAREMINDS CIO

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2025

Current financial year
Unrestricted
Restricted
funds
funds
2025
2025
Year
Year
Notes
£
£
Income from:
Voluntary income
3
41,244
-
Charitable activities
4
335,563
19,198
Investments
5
522
-
Total income
377,329
19,198
Expenditure on:
Fundraising and publicity
6
702
149
Charitable activities
7
302,756
12,079
Total expenditure
303,458
12,228
Net income
73,871
6,970
Transfers between funds
16,921
(16,921)
Net movement in funds
8
90,792
(9,951)
Reconciliation of funds:
Fund balances at 1 January 2025
32,485
20,619
Fund balances at 31 December 2025
123,277
10,668
Total
2025
Year
15
£
41,244
354,761
522
396,527
851
314,835
315,686
80,841
-
80,841
53,104
133,945
Total
2024
months
£
5,000
301,441
212
306,653
12,567
263,810
276,377
30,276
-
30,276
22,828
53,104

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

RAREMINDS CIO

STATEMENT OF FINANCIAL ACTIVITIES (CONTINUED) INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2025

Prior financial year
Unrestricted
Restricted
funds
funds
2024
2024
15 months
15 months
15
Notes
£
£
Income from:
Voluntary income
3
-
5,000
Charitable activities
4
282,863
18,578
Investments
5
212
-
Total income
283,075
23,578
Expenditure on:
Fundraising and publicity
6
12,567
-
Charitable activities
7
260,851
2,959
Total expenditure
273,418
2,959
Net income and movement in funds
9,657
20,619
Reconciliation of funds:
Fund balances at 1 January 2024
22,828
-
Fund balances at 31 December 2024
32,485
20,619
Total
2024
months
£
5,000
301,441
212
306,653
12,567
263,810
276,377
30,276
22,828
53,104

RAREMINDS CIO

BALANCE SHEET

AS AT 31 DECEMBER 2025

Notes
Current assets
Debtors
12
Cash at bank and in hand
Creditors: amounts falling due within
one year
13
Net current assets
The funds of the charity
Restricted income funds
16
Unrestricted funds
17
2025
£
16,968
123,437
140,405
(6,460)
£
133,945
10,668
123,277
133,945
2024
£
35,780
62,840
98,620
(45,516)
£
53,104
20,619
32,485
53,104

The financial statements were approved by the trustees on 29 July 2026

Paul Stevens Paul Stevens Michael Hartnett Trustee Trustee

Michael Hartnett

RAREMINDS CIO

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025

1 Accounting policies

Charity information

Rareminds CIO is a Charitable Incorporated Organisation.

1.1 Basis of preparation

The financial statements have been prepared in accordance with the charity's governing document, the Charities Act 2011, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)". The charity is a Public Benefit Entity as defined by FRS 102.

The charity has taken advantage of the provisions in the SORP for charities not to prepare a statement of cash flows.

The financial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has involved following the Statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulations but which has since been withdrawn.

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

Endowment funds are subject to specific conditions by donors that the capital must be maintained by the charity.

1.4 Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

RAREMINDS CIO

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

1 Accounting policies

(Continued)

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use.

1.6 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled.

RAREMINDS CIO

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

1 Accounting policies

(Continued)

1.8 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9 Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3 Income from voluntary income

Unrestricted
Restricted
funds
funds
2025
2025
Year
Year
£
£
Donations and gifts
6,244
-
Grants
35,000
-
41,244
-
Grants
Parexel MMS Europe
Limited
25,000
-
Takeda UK Limited
5,000
-
Amicus Therapeutics UK
Operations Limited
5,000
-
35,000
-
Total
Unrestricted
Restricted
Total
funds
funds
2025
2024
2024
2024
Year
15 months
15 months
15 months
£
£
£
£
6,244
-
5,000
5,000
35,000
-
-
-
41,244
-
5,000
5,000
25,000
-
-
-
5,000
-
-
-
5,000
-
-
-
35,000
-
-
-
Total
Unrestricted
Restricted
Total
funds
funds
2025
2024
2024
2024
Year
15 months
15 months
15 months
£
£
£
£
6,244
-
5,000
5,000
35,000
-
-
-
41,244
-
5,000
5,000
25,000
-
-
-
5,000
-
-
-
5,000
-
-
-
35,000
-
-
-
5,000
-
-
-
-

RAREMINDS CIO

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

4 Income from charitable activities

Unrestricted
Restricted
funds
funds
2025
2025
£
£
Charitable activities
Clinical services income
301,401
-
Consultancy income
34,162
-
Performance related
grants
-
19,198
335,563
19,198
Total
Unrestricted
Restricted
funds
funds
2025
2024
2024
£
£
£
301,401
233,959
-
34,162
48,904
-
19,198
-
18,578
354,761
282,863
18,578
Total
2024
£
233,959
48,904
18,578
301,441

Performance related grants analysis

Charitable Charitable
activities activities
2025 2024
£ £
National Lottery - 18,578
Vertex Pharmaceuticals 4,538 -
Blueprint Medicine 7,500 -
Kyowa Kirin 3,500 -
Chiesi 3,660 -
19,198 18,578

5 Income from investments

Unrestricted Unrestricted
funds funds
2025 2024
Year 15 months
£ £
Interest receivable 522 212

RAREMINDS CIO

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

6 Expenditure on fundraising and publicity

Unrestricted Restricted Total Unrestricted Restricted Total
funds funds funds funds
2025 2025 2025 2024 2024 2024
Year Year Year 15 months 15 months 15 months
£ £ £ £ £ £
Fundraising and publicity
Fundraising and publicity 702 149 851 12,567 - 12,567

7 Expenditure on charitable activities

Charitable Charitable
activities activities
2025 2024
Year 15 months
£ £
Direct costs
Staff costs 108,979 -
Clinicians and supervision fees 185,860 187,569
Website costs 4,882 6,274
Development costs - 26,212
Professional and consultancy fees 857 35,485
Office costs 7,983 3,998
Insurance 1,620 1,029
Training 2,494 1,879
Governance costs 2,160 1,364
314,835 263,810
Analysis by fund
Unrestricted funds 302,756 260,851
Restricted funds 12,079 2,959
314,835 263,810
8 Net movement in funds 2025 2024
£ £
The net movement in funds is stated after charging/(crediting):
Fees payable for the independent examination of the charity's financial
statements 2,160 1,364

9 Trustees

None of the trustees (or any persons connected with them) received any remuneration or benefits from the charity during the year.

RAREMINDS CIO

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

10 Employees

The average monthly number of employees, including trustees, during the year was:

Trustees
Senior Management Team
Total
Employment costs
Wages and salaries
Other pension costs
There were no employees whose annual remuneration was more than £60,000.
Remuneration of key management personnel
The remuneration of key management personnel was as follows:
Aggregate compensation
2025
Number
4
3
7
2025
£
106,681
2,298
108,979
2025
£
108,979
2024
Number
4
-
4
2024
£
-
-
-
2024
£
-

11 Taxation

The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.

12 Debtors

Debtors
2025 2024
Amounts falling due within one year: £ £
Trade debtors 16,968 35,780

RAREMINDS CIO

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

13
Creditors: amounts falling due within one year
2025
Notes
£
Deferred income
14
-
Trade creditors
3,797
Other creditors
503
Accruals
2,160
6,460
14
Deferred income
2025
£
Other deferred income
-
Deferred income is included in the financial statements as follows:
2025
£
Deferred income is included within:
Current liabilities
-
2025
£
Movements in the year:
Deferred income at 1 January 2025
30,000
Released from previous periods
(30,000)
Resources deferred in the year
-
Deferred income at 31 December 2025
-
15
Retirement benefit schemes
2025
Defined contribution schemes
£
Charge to profit or loss in respect of defined contribution schemes
2,298
2024
£
30,000
14,742
-
774
45,516
2024
£
30,000
2024
£
30,000
2024
£
-
-
30,000
30,000
2024
£
-

The charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund.

RAREMINDS CIO

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

16 Restricted funds

The restricted funds of the charity comprise the unexpended balances of donations and grants held on trust subject to specific conditions by donors as to how they may be used.

At 1 January Incoming Resources Transfers At 31
2025 resources expended December
2025
£ £ £ £ £
National Lottery - Wales 7,913 - (700) (6,704) 509
National Lottery - England 7,706 - (349) (7,307) 50
Takeda 5,000 - - (5,000) -
Recordati Rare Diseases UK - - - 2,090 2,090
Vertex Pharmaceuticals - 4,538 (3,499) - 1,039
Blueprint Medicine - 7,500 (1,897) - 5,603
Kyowa Kirin International - 3,500 (3,036) - 464
Chiesi - 3,660 (2,747) - 913
20,619 19,198 (12,228) (16,921) 10,668
Previous year: At 1 January Incoming Resources Transfers At 31
2024 resources expended December
2024
£ £ £ £ £
National Lottery - Wales - 9,393 (1,480) - 7,913
National Lottery - England - 9,185 (1,479) - 7,706
Takeda - 5,000 - - 5,000
- 23,578 (2,959) - 20,619

National Lottery Wales was funding for rare disease mental health and wellbeing resources for people impacted by a rare condition living in Wales (including translations).

National Lottery England was funding for online mental health workshops and resources for people impacted by rare conditions living in England.

Recordati Rare Diseases UK was funding for service work for two workshops.

Vertex Pharmaceuticals, Blueprint Medicine, Kyowa Kirin International and Chiesi are funding for phase 3 of the Rareminds Wellbeing Hub to provide free online mental health resources for people impacted by rare conditions.

RAREMINDS CIO

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2025

17 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

At 1
General funds
Previous year:
At 1
General funds
January
2025
Incoming
resources
Resources
expended
Transfers
At 31
December
2025
£
£
£
£
£
32,485
377,329
(303,458)
16,921
123,277
January
2024
Incoming
resources
Resources
expended
Transfers
At 31
December
2024
£
£
£
£
£
22,828
283,075
(273,418)
-
32,485

18 Analysis of net assets between funds

Unrestricted
Restricted
funds
funds
2025
2025
£
£
At 31 December 2025:
Current assets/(liabilities)
123,277
10,668
123,277
10,668
Unrestricted
Restricted
funds
funds
2024
2024
£
£
At 31 December 2024:
Current assets/(liabilities)
32,485
20,619
32,485
20,619
Total
2025
£
133,945
133,945
Total
2024
£
53,104
53,104

19 Related party transactions

There were no disclosable related party transactions during the year (2024 - none).